These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 11348641)

  • 1. In vitro evaluation of surfactants with eucalyptus oil for respiratory distress syndrome.
    Banerjee R; Bellare JR
    Respir Physiol; 2001 Jun; 126(2):141-51. PubMed ID: 11348641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of in vitro surface properties of clove oil-phospholipid suspensions with those of ALEC, Exosurf and Survanta.
    Banerjee R; Bellare JR
    Pulm Pharmacol Ther; 2001; 14(2):85-91. PubMed ID: 11273788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrastructure of exogenous surfactants using cryogenic scanning electron microscopy.
    Banerjee R; Bellare JR
    J Biomater Appl; 2001 Jan; 15(3):230-40. PubMed ID: 11261601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of dynamic surface properties of therapeutic surfactants and lung phospholipids.
    Banerjee R; Puniyani RR; Bellare JR
    J Biomater Appl; 2000 Oct; 15(2):140-59. PubMed ID: 11081642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of calcium on the surface properties of phospholipid monolayers with respect to surfactant formulations in respiratory distress syndrome.
    Banerjee R; Bellare J
    Biomed Mater Eng; 2001; 11(1):43-53. PubMed ID: 11281578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biophysical properties of protein-free, totally synthetic pulmonary surfactants, ALEC and Exosurf, in comparison with surfactant TA.
    Takahashi A; Nemoto T; Fujiwara T
    Acta Paediatr Jpn; 1994 Dec; 36(6):613-8. PubMed ID: 7871968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surface tension of therapeutic surfactants (exosurf neonatal, infasurf, and survanta) as evaluated by standard methods and criteria.
    Scarpelli EM; David E; Cordova M; Mautone AJ
    Am J Perinatol; 1992; 9(5-6):414-9. PubMed ID: 1418146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Biophysical models in investigations of exogenous surfactant activities on the surface tension and their theurapeutic effectiveness].
    Todorov R; Iordanova A; Georgiev GA; Petkova Kh; Stoimenova E; Georgieva R; Khristova E; Vasiliev Kh; Lalchev Z
    Akush Ginekol (Sofiia); 2007; 46 Suppl 1():29-36. PubMed ID: 18175392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Importance of hydrophobic apoproteins as constituents of clinical exogenous surfactants.
    Hall SB; Venkitaraman AR; Whitsett JA; Holm BA; Notter RH
    Am Rev Respir Dis; 1992 Jan; 145(1):24-30. PubMed ID: 1731593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controversies: synthetic or natural surfactant. The case for natural surfactant.
    Halliday HL
    J Perinat Med; 1996; 24(5):417-26. PubMed ID: 8950721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro inactivation of pulmonary surfactant replacement preparations by serum albumin.
    Bummer PM; Sanders LP; Pauly TH; Gillespie MN
    Am J Med Sci; 1994 Jun; 307(6):401-4. PubMed ID: 8198144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of exogenous pulmonary surfactants on mortality rate in neonatal respiratory distress syndrome: A network meta-analysis of randomized controlled trials.
    Zhang L; Cao HY; Zhao S; Yuan LJ; Han D; Jiang H; Wu S; Wu HM
    Pulm Pharmacol Ther; 2015 Oct; 34():46-54. PubMed ID: 26296793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Tension activity of pulmonary surfactant: adsorption of liposomes of model phospholipids].
    Denizot BA; Fain B; Tchoreloff PC; Bonanno LM; Proust JE; Lindenbaum A; Dehan M; Puisieux F
    Ann Pharm Fr; 1991; 49(3):151-7. PubMed ID: 1929119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Scoring of surface parameters of physiological relevance to surfactant therapy in respiratory distress syndrome.
    Banerjee R; Bellare JR
    J Appl Physiol (1985); 2001 Apr; 90(4):1447-54. PubMed ID: 11247946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colfosceril palmitate. A review of the therapeutic efficacy and clinical tolerability of a synthetic surfactant preparation (Exosurf Neonatal) in neonatal respiratory distress syndrome.
    Dechant KL; Faulds D
    Drugs; 1991 Nov; 42(5):877-94. PubMed ID: 1723378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resistance of different surfactant preparations to inactivation by meconium.
    Herting E; Rauprich P; Stichtenoth G; Walter G; Johansson J; Robertson B
    Pediatr Res; 2001 Jul; 50(1):44-9. PubMed ID: 11420417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the changes in the a/A oxygen ratio after administration of two surfactants for the treatment of neonatal respiratory distress syndrome.
    Bassiouny MR; Remo C; Cherian E
    J Trop Pediatr; 1997 Feb; 43(1):38-41. PubMed ID: 9078827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Commercial versus native surfactants. Surface activity, molecular components, and the effect of calcium.
    Bernhard W; Mottaghian J; Gebert A; Rau GA; von Der HARDT H; Poets CF
    Am J Respir Crit Care Med; 2000 Oct; 162(4 Pt 1):1524-33. PubMed ID: 11029372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A spreading technique for forming film in a captive bubble.
    Putz G; Walch M; Van Eijk M; Haagsman HP
    Biophys J; 1998 Nov; 75(5):2229-39. PubMed ID: 9788918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative efficacy of exosurf and survanta surfactants on early clinical course of respiratory distress syndrome and complications of prematurity.
    Modanlou HD; Beharry K; Padilla G; Norris K; Safvati S; Aranda JV
    J Perinatol; 1997; 17(6):455-60. PubMed ID: 9447532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.